Drugs / Lispro Mid Mix
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00279201 | Dec 2005 → Nov 2009 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lispro Mid Mix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00279201 ↗ |
| Known as | lispro mix 50/50 | “patients previously on lispro mix 75/25 will receive lispro mix 50/50 (50% insulin lispro protamine suspension, 50% lispro) thrice daily or basal/bolus therapy.” PMID 19885269 ↗ Sep 2008 |
| Modality | Protein / enzyme biologic | “insulin lispro protamine suspension” PMID 19885269 ↗ Sep 2008 |
| Route | Subcutaneous | “Lispro Mid Mix subcutaneous injection 3 times daily.” NCT00279201 ↗ |